G-CSF, rt-PA and combination therapy after experimental thromboembolic stroke

Experimental and Translational Stroke Medicine

Volumn 2, Issue 1, 2010, Pages

  Kollmar, Rainer ^a   Henninger, Nils ^b   Urbanek, Christian ^c   Schwab, Stefan ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c Neurology Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION SIZE; CONTROLLED STUDY; FUNCTIONAL ASSESSMENT; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; STAINING; STROKE; SURVIVAL; THROMBOEMBOLIC STROKE;

EID: 77953177163     PISSN: None     EISSN: 20407378     Source Type: Journal    
DOI: 10.1186/2040-7378-2-9     Document Type: Article

References (27)

1. Schabitz WR, Kollmar R, Schwaninger M, Juettler E, Bardutzky J, Scholzke MN, Sommer C, Schwab S. Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 2003, 34:745-51. 10.1161/01.STR.0000057814.70180.17, 12624302.
2. Six I, Gasan G, Mura E, Bordet R. Beneficial effect of pharmacological mobilization of bone marrow in experimental cerebral ischemia. Eur J Pharmacol 2003, 458:327-8. 10.1016/S0014-2999(02)02785-1, 12504790.
3. Komine-Kobayashi M, Zhang N, Liu M, Tanaka R, Hara H, Osaka A, Mochizuki H, Mizuno Y, Urabe T. Neuroprotective effect of recombinant human granulocyte colony-stimulating factor in transient focal ischemia of mice. J Cereb Blood Flow Metab 2006, 26:402-13. 10.1038/sj.jcbfm.9600195, 16049425.
4. Solaroglu I, Tsubokawa T, Cahill J, Zhang JH. Anti-apoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat. Neuroscience 2006, 143:965-74. 10.1016/j.neuroscience.2006.09.014, 1820637, 17084035.
5. Gibson CL, Bath PM, Murphy SP. G-CSF reduces infarct volume and improves functional outcome after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 2005, 25:431-9. 10.1038/sj.jcbfm.9600033, 15660101.
6. Shyu WC, Lin SZ, Yang HI, Tzeng YS, Pang CY, Yen PS, Li H. Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation 2004, 110:1847-54. 10.1161/01.CIR.0000142616.07367.66, 15381647.
7. Schneider A, Kruger C, Steigleder T, Weber D, Pitzer C, Laage R, Aronowski J, Maurer MH, Gassler N, Mier W, Hasselblatt M, Kollmar R, Schwab S, Sommer C, Bach A, Kuhn HG, Schabitz WR. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 2005, 115:2083-98. 10.1172/JCI23559, 1172228, 16007267.
8. Schneider A, Wysocki R, Pitzer C, Kruger C, Laage R, Schwab S, Bach A, Schabitz WR. An extended window of opportunity for G-CSF treatment in cerebral ischemia. BMC Biol 2006, 18(4):36.
9. Schneider A, Kuhn HG, Schabitz WR. A role for G-CSF (granulocyte-colony stimulating factor) in the central nervous system. Cell Cycle 2005, 4:1753-7.
10. Han JL, Blank T, Schwab S, Kollmar R. Inhibited glutamate release by granulocyte-colony stimulating factor after experimental stroke. Neurosci Lett 2008, 432:167-9. 10.1016/j.neulet.2007.07.056, 18255224.
11. Shyu WC, Lin SZ, Lee CC, Liu DD, Li H. Granulocyte colony-stimulating factor for acute ischemic stroke: a randomizedcontrolled trial. CMAJ 2006, 174:927-33. 1405861, 16517764.
12. Kawada H, Takizawa S, Takanashi T, Morita Y, Fujita J, Fukuda K, Takagi S, Okano H, Ando K, Hotta T. Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells. Circulation 2006, 113:701-10. 10.1161/CIRCULATIONAHA.105.563668, 16461843.
13. Sprigg N, Bath PM, Zhao L, Willmot MR, Gray LJ, Walker MF, Dennis MS, Russell N. Granulocyte-colony-stimulating factor mobilizes bone marrow stem cells in patients with subacute ischemic stroke: the Stem cell Trial of recovery EnhanceMent after Stroke (STEMS) pilot randomized, controlled trial (ISRCTN 16784092). Stroke 2006, 37:2979-83. 10.1161/01.STR.0000248763.49831.c3, 17082474.
14. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004, 363:768-774. 10.1016/S0140-6736(04)15692-4, 15016487.
15. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D, . ECASS Investigators Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008, 359:1317-29. 10.1056/NEJMoa0804656, 18815396, ECASS Investigators.
16. Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K, Schellinger PD, Bohn M, Becker H, Wegrzyn M, Jähnig P, Herrmann M, Knauth M, Bähr M, Heide W, Wagner A, Schwab S, Reichmann H, Schwendemann G, Dengler R, Kastrup A, Bartels C, . EPO Stroke Trial Group Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 2009, 40:e647-56. 10.1161/STROKEAHA.109.564872, 19834012, EPO Stroke Trial Group.
17. Frietsch T, Krafft P, Piepgras A, Lenz C, Kuschinsky W, Waschke KF. Relationship between local cerebral blood flow and metabolism during mild and moderate hypothermia in rats. Anesthesiology 2000, 92:754-63. 10.1097/00000542-200003000-00019, 10719954.
18. Kollmar R, Henninger N, Bardutzky J, Schellinger PD, Schabitz WR, Schwab S. Combination therapy of moderate hypothermia and thrombolysis in experimental thromboembolic stroke - an MRI study. Exp Neurol 2004, 190:204-212. 10.1016/j.expneurol.2004.07.006, 15473993.
19. Korninger C, Collen D. Studies on specific fibrinolytic effect of human extrinsic plasminogen activator in human blood and in various animal species in vitro. Thromb Haemost 1981, 46:561-565.
20. Heiland S, Benner T, Reith W. Perfusion-weighted MRI using gadobutrol as a contrast agent in a rat stroke model. J Magn Reson Imaging 1997, 7:1109-1115. 10.1002/jmri.1880070625, 9400856.
21. Heiland S, Sartor K. Magnetic resonance tomography in stroke: its meth-odological bases and clinical use [in German]. Rofo Fortschr Geb Ront-genstr Neuen Bildgeb Verfahr 1999, 171:3-14.
22. Vogel J, Mobius C, Kuschinsky W. Early delineation of ischemic tissue in rat brain cryosections by high-contrast staining. Stroke 1999, 30:1134-1141.
23. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Meta 1990, 10:290-293.
24. Menzies SA, Hoff JT, Betz AL. Middle cerebral artery occlusion in rats: A neurological and pathological evaluation of a reproducible model. Neurosurgery 1992, 31:100-106. 10.1097/00006123-199207000-00014, 1641086.
25. Aronowski J, Strong R, Grotta JC. Reperfusion injury: Demonstration of brain damage produced by reperfusion after transient focal ischemia in rats. J Cereb Blood Flow Metab 1997, 17:1048-1056. 10.1097/00004647-199710000-00006, 9346429.
26. Asahi M, Asahi K, Wang X, Lo EH. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats. J Cereb Blood Flow Metab 2000, 20:452-457. 10.1097/00004647-200003000-00002, 10724108.
27. Wang X, Asahi M, Lo EH. Tissue type plasminogen activator amplifies hemoglobin-induced neurotoxicity in rat neuronal cultures. Neurosci Lett 1999, 274:79-82. 10.1016/S0304-3940(99)00682-5, 10553942.